{
    "clinical_study": {
        "@rank": "69020", 
        "brief_summary": {
            "textblock": "The purpose of this study is to see whether taking indinavir (IDV) plus ritonavir (RTV) plus\n      stavudine (d4T) plus lamivudine (3TC) 2 times each day is safe and can lower the level of\n      HIV in the blood."
        }, 
        "brief_title": "Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients take IDV plus RTV plus d4T plus 3TC twice daily for 24 weeks. Every 4 weeks,\n      patients have physical exams and laboratory tests of blood and urine, and CD4 cell counts\n      and plasma viral RNA are measured. At Week 24, the proportion of patients with plasma viral\n      RNA below 400 copies/ml is determined to identify any clinically meaningful antiretroviral\n      activity for the drug regimen. An observed response proportion of 80% or higher will be\n      considered clinically meaningful."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients may be eligible for this study if they:\n\n          -  Are HIV-positive.\n\n          -  Have a CD4 cell count of 75 cells/mm3 or more and a viral load of 5,000 copies/ml or\n             more.\n\n          -  Are age 16 or older (consent of a parent or guardian required if under 18).\n\n          -  Agree to practice abstinence or use barrier methods of birth control (such as\n             condoms).\n\n          -  Are willing to stop taking all anti-HIV drugs except study drugs. (Patients may be\n             able to continue taking drugs for other infections.)\n\n        Exclusion Criteria\n\n        Patients will not be eligible for this study if they:\n\n          -  Have cancer, lung disease, severe hepatitis, or active AIDS-related infections.\n             (Certain AIDS-related infections such as Kaposi's sarcoma may be allowed).\n\n          -  Have ever taken 3TC, abacavir (ABC), or a protease inhibitor (such as IDV or RTV).\n\n          -  Have changed their medications in the last 2 weeks.\n\n          -  Are allergic to IDV, RTV, d4T, or 3TC.\n\n          -  Have used certain medications (see the technical summary for more detail).\n\n          -  Are pregnant or breast-feeding."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": "80", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002241", 
            "org_study_id": "246T", 
            "secondary_id": [
                "094-00", 
                "CRX463"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "Indinavir sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Ritonavir", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Lamivudine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Stavudine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "HIV Protease Inhibitors", 
                "Indinavir", 
                "Ritonavir", 
                "Stavudine", 
                "Lamivudine", 
                "Reverse Transcriptase Inhibitors"
            ]
        }, 
        "keyword": [
            "Drug Therapy, Combination", 
            "Stavudine", 
            "HIV Protease Inhibitors", 
            "Ritonavir", 
            "Lamivudine", 
            "Indinavir", 
            "Reverse Transcriptase Inhibitors", 
            "Anti-HIV Agents", 
            "Viral Load"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "Univ of Alabama at Birmingham"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92101"
                    }, 
                    "name": "Apogee Med Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94110"
                    }, 
                    "name": "Univ of California at San Francisco Gen Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94118"
                    }, 
                    "name": "Kaiser Foundation Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94114"
                    }, 
                    "name": "HIV Institute / Davies Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "Univ of Miami School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60657"
                    }, 
                    "name": "AIDS Research Alliance - Chicago"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Tulane Univ School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brookline", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02146"
                    }, 
                    "name": "CRI New England"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10456"
                    }, 
                    "name": "Bronx Lebanon Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10467"
                    }, 
                    "name": "Montefiore Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brooklyn", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11203"
                    }, 
                    "name": "SUNY Health Sciences Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10019"
                    }, 
                    "name": "St Lukes / Roosevelt Hosp / HIV Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10014"
                    }, 
                    "name": "Chelsea Village Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "Liberty Med Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Mount Sinai Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Mark Watkins"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Univ of Texas / Thomas Street Clinic"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Multicenter, Open-Label, 24-Week Pilot Study to Evaluate the Safety and Efficacy of Indinavir Sulfate 800 Mg b.i.d. in Combination With Ritonavir 100 Mg/d4T/3TC b.i.d. in HIV-Infected Individuals", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002241"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Merck Sharp & Dohme Corp.", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2001"
    }, 
    "geocoordinates": {
        "AIDS Research Alliance - Chicago": "41.878 -87.63", 
        "Apogee Med Group": "32.715 -117.157", 
        "Bronx Lebanon Hosp Ctr": "40.85 -73.867", 
        "CRI New England": "42.332 -71.121", 
        "Chelsea Village Med Ctr": "40.714 -74.006", 
        "HIV Institute / Davies Med Ctr": "37.775 -122.419", 
        "Kaiser Foundation Hospital": "37.775 -122.419", 
        "Liberty Med Group": "40.714 -74.006", 
        "Mark Watkins": "39.952 -75.164", 
        "Montefiore Med Ctr": "40.85 -73.867", 
        "Mount Sinai Med Ctr": "40.714 -74.006", 
        "SUNY Health Sciences Ctr": "40.653 -73.959", 
        "St Lukes / Roosevelt Hosp / HIV Center": "40.714 -74.006", 
        "Tulane Univ School of Medicine": "29.951 -90.072", 
        "Univ of Alabama at Birmingham": "33.521 -86.802", 
        "Univ of California at San Francisco Gen Hosp": "37.775 -122.419", 
        "Univ of Miami School of Medicine": "25.789 -80.226", 
        "Univ of Texas / Thomas Street Clinic": "29.76 -95.369"
    }
}